Capecitabine (X) plus weekly irinotecan (CAPIRI) as first-line treatment in patients (pts) with metastatic colorectal cancer (MCRC): findings from a phase II trial of the Brazilian Oncology Consordium

被引：0
|
作者：
Barrios, Carlos Henrique [1 ]
Viola, Fabiana [1 ]
Coura, Luciana [2 ]
Del Giglio, Auro [3 ]
Malhias, Clarissa [1 ,4 ]
机构：
[1] Hosp Sao Lucas PUC, Porto Alegre, RS, Brazil
[2] InCA Inst Nacl Canc, Rio De Janeiro, Brazil
[3] Hosp Fac Med ABC, Sao Bernardo Do Campo, Brazil
[4] Nucleo Oncol Bahia, Salvador, BA, Brazil
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：89 / 90
页数：2
相关论文
共 50 条
  • [1] Capecitabine plus irinotecan (CAPIRI) as first-line treatment for patients (PTS) with metastatic colorectal cancer (MCRC)
    Laudani, Agata
    Savio, Giuseppina
    Leonardi, Vita
    Palmisano, Valentina
    Rondello, Giacomo
    Alu, Massimiliano
    Pepe, Alessio
    Calabria, Caterina
    Usset, Antonella
    Agostara, Biagio
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 119 - 119
  • [2] Capecitabine plus irinotecan (CAPIRI) as first-line treatment for patients (Pts) with metastatic colorectal cancer (MCRC)
    Laudani, A.
    Savio, G.
    Leonardi, V.
    Palmisano, V.
    Tartaglia, L.
    Manuguerra, G.
    Pepe, A.
    Alu, M.
    Usset, A.
    Agostara, B.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 6 - 6
  • [3] CAPECITABINE AND IRINOTECAN (CAPIRI) AS FIRST -LINE TREATMENT FOR PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)
    Bounedjar, A.
    Smail, F.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 67 - 68
  • [4] CAPECITABINE AND IRINOTECAN (CAPIRI) AS FIRST - LINE TREATMENT FOR PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)
    Adda, B.
    Farida, S.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 73 - 73
  • [5] A phase II trial of a biweekly schedule of capecitabine (X) plus irinotecan (1) as first-line treatment in patients (pts) with metastatic colorectal cancer (MCRC).
    Garcia-Alfonso, P
    Perez-Manga, G
    Gonzalez, MC
    Lopez, P
    Gonzalez, E
    Belon, J
    Molina, M
    Pachon, V
    Iglesias, L
    Siso, I
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 256S - 256S
  • [6] Capecitabine (X) plus irinotecan (XELIRI) as first-line treatment for metastatic colorectal cancer (MCRC): Final safety findings from a phase II trial.
    Patt, YZ
    Liebmann, J
    Diamandidis, D
    Eckhardt, SG
    Javle, M
    Justice, GR
    Keiser, W
    Lee, FC
    Miller, W
    Lin, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 270S - 270S
  • [7] Final efficacy and safety findings from a phase II trial of capecitabine (X) plus irinotecan (XELIRI) as first-line treatment for metastatic colorectal cancer (MCRC)
    Patt, Yehuda
    Liebmann, James
    Diamandidis, Dimitrios
    Eckhardt, Gail
    Javle, Milind
    Justice, Glen
    Keiser, Leroy W.
    Lee, Fa-Chyi
    Miller, William
    Lin, Edward
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 88 - 88
  • [8] Capetabine plus irinotecan (CAPIRI) as first line treatment for patients with metastatic colorectal cancer(MCRC)
    Laudani, A.
    Alu, M.
    Leonardi, V
    Savio, G.
    Pepe, A.
    Palmisano, V
    Targaglia, L.
    Porretto, C.
    Manuguerra, G.
    Calabria, C.
    Agostara, B.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : VII41 - VII41
  • [9] Capecitabine plus irinotecan plus bevacizurnab as first-line therapy for patients (pts) with metastatic colorectal cancer (MCRC): preliminary phase II study results
    Beslija, S.
    Banjin, M.
    Jungic, S.
    Obralic, N.
    Kecman-Malcic, G.
    Rakita, I.
    Salkic, B.
    Pasic, A.
    Tinjic, L.
    Ajanovic, E.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 256 - 257
  • [10] Preliminary phase II study results of capecitabine (X) plus irinotecan (I) plus bevacizumab (A) as first-line therapy for patients (pts) with metastatic colorectal cancer (MCRC)
    Beslija, S.
    Banjin, M.
    Jungic, S.
    Obralic, N.
    Kecman-Malcic, G.
    Rakita, I.
    Salkic, B.
    Pasic, A.
    Tinjic, L.
    Ajanovic, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345